BG
TERN icon

Bellevue Group’s Terns Pharmaceuticals TERN Stock Holding History

Bellevue Group’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,061,753
Closed -$5.88M – 164
2024
Q4 		$5.88M Buy
1,061,753
+19,618
+2% +$109K 0.11% 91
2024
Q3 		$8.69M Buy
+1,042,135
New +$8.69M 0.14% 87